A Systematic Review and Meta-analysis of the Association Between Vitamin K Antagonist Use and Fracture
Vitamin K antagonist (VKA) anticoagulant use is suspected to increase the risk of bone fracture through inhibition of vitamin K–dependent cofactors of bone formation, an effect not seen with non-vitamin K antagonist oral anticoagulants (NOACs). The purpose of our systematic review and meta-analysis is to investigate the association between VKA use and fracture.
We searched PubMed, EMBASE, and Cochrane Library for studies analyzing fracture in adults using VKAs versus controls. Two authors independently reviewed articles. We assessed for risk of bias using the Newcastle-Ottawa Quality Assessment Scale and the Cochrane Risk of Bias Tool and calculated pooled effects using random effects models.
We included 23 articles (22 observational studies and 1 randomized controlled trial), studying 1,121,582 subjects. There was no increased odds of fracture in VKA users versus controls (pooled OR 1.01, 95% CI 0.89, 1.14) or in VKA users versus NOAC users (pooled OR 0.95, 95% CI 0.78, 1.15). Subjects using a VKA for 1 year or longer did not have increased odds of fracture (pooled OR 1.07, 95% CI 0.90, 1.27). Compared to controls, there was increased odds of fracture in women (pooled OR 1.11, 95% CI 1.02, 1.21) and older VKA users (≥ 65) (pooled OR 1.07, 95% CI 1.01, 1.14).
We found no increase in odds of fracture in VKA users versus controls or NOAC users. There was a small increase in odds of fracture among female and elderly VKA users, which may not be clinically important when accounting for other considerations in choosing an anticoagulant. Our findings suggest that, when anticoagulation is necessary, fracture risk should not be a major consideration in choice of an agent. Future studies directly comparing VKA to NOAC users and studies with longer duration of VKA use may be needed.
KEY WORDSmeta-analysis osteoporosis systematic reviews
We would like to thank Heather Healy for the assistance with the literature search and Robert Wallace and Rich Hoffman for the assistance with editing the manuscript.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they do not have a conflict of interest.
- 1.U.S. Food and Drug Administration [Internet]. Silver Spring, MD: U.S. Food and Drug Administration; c2018 [updated 2015 Oct; cited 2018 Jan 15]. Coumadin Prescribing Information; [about 1 screen]. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/009218s115lbl.pdf. Accessed 15 Jan 2018.
- 10.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. Ottawa: The Ottawa Hospital research Institute; c2018 [updated 2018; cited 2018 Jan 7]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 7 Jan 2018.
- 11.Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343.Google Scholar
- 12.Review Manager. 5.3 ed. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration; 2011.Google Scholar
- 13.Sheskin D. Handbook of parametric and nonparametric statistical procedures. 5th ed: Boca Raton: Chapman & Hall/CRC Press; 2011.Google Scholar
- 28.Norby FL, Bengtson LGS, Lutsey PL, Chen LY, MacLehose RF, Chamberlain AM, et al. Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord. 2017;17(1).Google Scholar
- 30.Pieracci FM, Eachempati SR, Shou J, Hydo LJ, Barie PS. Use of long-term anticoagulation is associated with traumatic intracranial hemorrhage and subsequent mortality in elderly patients hospitalized after falls: analysis of the New York State Administrative Database. J Trauma. 2007;63(3):519–24.CrossRefGoogle Scholar
- 37.Wang SH, Chang YS, Liu CJ, Lai CC, Chen WS, Chen TJ, et al. Association of systemic lupus erythematosus with a higher risk of cervical but not trochanteric hip fracture: A nationwide population-based study. Arthritis Care Res. 2013;65(10):1674–81.Google Scholar